Scientific Library
- Acute Coronary Syndrom
- ASCVD Prevention
- Bifurcation Stenting
- Cardio-Oncology
- Congestive Heart Failure
- DAPT Duration
- Drug Coated Balloon
- Fractional Flow Reserve
- IVUS Guidance
- Optical Coherence Tomography
- Pulmonary Hypertension
- Rotational Atherectomy
- Shear Stress
- Stenting Left Main
- Transcatheter Aortic Valve Replacement
- Percutaneous LAA Occlusion
- Mitral/Tricuspid Valvular Disease
- Other Relevant Articles
-
Quality of Care in Chinese Hospitals: Processes and Outcomes After ST-segment Elevation Myocardial InfarctionDowning NS, Wang Y, Krumholz HM et al. -
Effect of Pre-Hospital Crushed Prasugrel Tablets in Patients with STEMI Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH TrialGJ Vlachojannis , JM Wilschut , RF Vogel et al.
-
Aggressive lipid-lowering therapy after percutaneous coronary intervention – for whom and how?Z-V Lee.
-
Long-Term Coronary Functional Assessment of the Infarct-Related Artery Treated With Everolimus-Eluting Bioresorbable Scaffolds or Everolimus-Eluting Metallic Stents: Insights of the TROFI II TrialGomez-Lara J, Brugaletta S, Ortega-Paz L et al.
-
Fine particulate air pollution and hospital admissions and readmissions for acute myocardial infarction in 26 Chinese citiesLiu H, Tian Y, Hu Y et al.
-
Patterns of use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers among patients with acute myocardial infarction in China from 2001 to 2011: China PEACE-Retrospective AMI StudyLiu J, Masoudi FA, China PEACE Collaborative Group.
-
Comparison of the Preventive Efficacy of Rosuvastatin Versus Atorvastatin in Post-Contrast Acute Kidney Injury in Patients With ST-segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary InterventionYN Dai, JL Huang, DQ Yu et al.
-
Multivessel PCI Guided by FFR or Angiography for Myocardial InfarctionE Puymirat, G Cayla, for the FLOWER-MI Study Investigators et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
